Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Minutes”

579 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 579 results

Testing effectiveness (Phase 2)Study completedNCT03625323
What this trial is testing

Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC

Who this might be right for
NSCLCHNSCC
Immutep S.A.S. 187
Not applicableNot Yet RecruitingNCT06993896
What this trial is testing

Physical Activity During Chemo- and/or Immunotherapy for Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)
University Hospital Schleswig-Holstein 38
Early research (Phase 1)Study completedNCT00016237
What this trial is testing

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Bladder CancerKidney CancerLung Cancer
EMD Serono
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Testing effectiveness (Phase 2)Study completedNCT01059383
What this trial is testing

Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms

Who this might be right for
Gastroesophageal Reflux
Vecta Ltd. 52
Testing effectiveness (Phase 2)Study completedNCT02795156
What this trial is testing

Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

Who this might be right for
Non-small Cell Lung CarcinomaUrothelial CarcinomaGastrointestinal Carcinoma, Non-colon+1 more
SCRI Development Innovations, LLC 100
Early research (Phase 1)Looking for participantsNCT05780034
What this trial is testing

AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Who this might be right for
Relapsed/Refractory B-cell Malignancies
Accutar Biotechnology Inc 60
Not applicableActive Not RecruitingNCT06579963
What this trial is testing

Assessing the Effect of Cool Roofs on Health Using Smartwatches

Who this might be right for
Heart RateAll-day StepsDistance Walked+7 more
Aditi Bunker 800
Testing effectiveness (Phase 2)Study completedNCT00139711
What this trial is testing

Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 138
Not applicableStudy completedNCT06708312
What this trial is testing

The Effect Of Ears Acupuncture On Fitness Test 12 Minutes Running in Students Of Medical Faculty UNHAN RI

Who this might be right for
Sports Physical TherapyMilitary ActivityExercise Overtraining
Universitas Indonesia 63
Large-scale testing (Phase 3)Study completedNCT03676192
What this trial is testing

To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of Lung
Celltrion 689
Early research (Phase 1)UnknownNCT05780307
What this trial is testing

IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon-small Cell Lung CancerSmall Cell Lung Cancer+3 more
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 48
Not applicableStudy completedNCT06503081
What this trial is testing

Crohn's Disease - Inflammation and Microbial Proteolytic Activity

Who this might be right for
Crohn's Disease of Both Small and Large Intestine
McMaster University 30
Large-scale testing (Phase 3)Study completedNCT00276276
What this trial is testing

Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Small Cell
GlaxoSmithKline 141
Not applicableUnknownNCT03197857
What this trial is testing

Physical Condition and Bariatric Surgery

Who this might be right for
Obese Patients With Bariatric Surgery
University Hospital, Clermont-Ferrand 150
Not applicableStudy completedNCT02204800
What this trial is testing

Active Surveillance of the Small Renal Mass

Who this might be right for
Small Renal Mass, Kidney Cancer
Yale University 4
Not applicableNot Yet RecruitingNCT07502963
What this trial is testing

Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficacy of Chemotherapy in Adults With Breast, Lung and Colon Cancer

Who this might be right for
Breast CancerLung Cancer (Non-Small Cell)Colorectal Cancer+3 more
University of Vic - Central University of Catalonia 70
Testing effectiveness (Phase 2)Looking for participantsNCT06244771
What this trial is testing

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Who this might be right for
Advanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more
Frontier Medicines Corporation 403
Not applicableStudy completedNCT03578614
What this trial is testing

Impact of Physical Activity in Vascular Cognitive Impairment ( AFIVASC )

Who this might be right for
Vascular Cognitive Impairment
Instituto de Medicina Molecular João Lobo Antunes 104
Early research (Phase 1)WithdrawnNCT06982222
What this trial is testing

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+4 more
National Cancer Institute (NCI)
Next Page